[1]
Aluri J, Desai M, Gupta M, Dalvi A, Terance A, Rosenzweig SD, Stoddard JL, Niemela JE, Tamankar V, Mhatre S, Bargir U, Kulkarni M, Shah N, Aggarwal A, Lashkari HP, Krishna V, Govindaraj G, Kalra M, Madkaikar M. Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India. Frontiers in immunology. 2019:10():23. doi: 10.3389/fimmu.2019.00023. Epub 2019 Feb 4
[PubMed PMID: 30778343]
[2]
Wekell P, Hertting O, Holmgren D, Fasth A. Fifteen-minute consultation: Recognising primary immune deficiencies in children. Archives of disease in childhood. Education and practice edition. 2019 Oct:104(5):235-243. doi: 10.1136/archdischild-2018-315484. Epub 2019 Feb 7
[PubMed PMID: 30733240]
[3]
International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammartröm L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J. Primary immunodeficiencies: 2009 update. The Journal of allergy and clinical immunology. 2009 Dec:124(6):1161-78. doi: 10.1016/j.jaci.2009.10.013. Epub
[PubMed PMID: 20004777]
[4]
Gennery A. Recent advances in understanding RAG deficiencies. F1000Research. 2019:8():. pii: F1000 Faculty Rev-148. doi: 10.12688/f1000research.17056.1. Epub 2019 Feb 4
[PubMed PMID: 30800289]
Level 3 (low-level) evidence
[5]
Adenosine deaminase deficiency: a review., Flinn AM,Gennery AR,, Orphanet journal of rare diseases, 2018 Apr 24
[PubMed PMID: 29690908]
[6]
Modell V, Quinn J, Orange J, Notarangelo LD, Modell F. Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network. Immunologic research. 2016 Jun:64(3):736-53. doi: 10.1007/s12026-016-8784-z. Epub
[PubMed PMID: 26802037]
Level 3 (low-level) evidence
[7]
Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, Brokopp C, Brooks E, Caggana M, Celestin J, Church JA, Comeau AM, Connelly JA, Cowan MJ, Cunningham-Rundles C, Dasu T, Dave N, De La Morena MT, Duffner U, Fong CT, Forbes L, Freedenberg D, Gelfand EW, Hale JE, Hanson IC, Hay BN, Hu D, Infante A, Johnson D, Kapoor N, Kay DM, Kohn DB, Lee R, Lehman H, Lin Z, Lorey F, Abdel-Mageed A, Manning A, McGhee S, Moore TB, Naides SJ, Notarangelo LD, Orange JS, Pai SY, Porteus M, Rodriguez R, Romberg N, Routes J, Ruehle M, Rubenstein A, Saavedra-Matiz CA, Scott G, Scott PM, Secord E, Seroogy C, Shearer WT, Siegel S, Silvers SK, Stiehm ER, Sugerman RW, Sullivan JL, Tanksley S, Tierce ML 4th, Verbsky J, Vogel B, Walker R, Walkovich K, Walter JE, Wasserman RL, Watson MS, Weinberg GA, Weiner LB, Wood H, Yates AB, Puck JM, Bonagura VR. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014 Aug 20:312(7):729-38. doi: 10.1001/jama.2014.9132. Epub
[PubMed PMID: 25138334]
[8]
Al-Herz W, Al-Mousa H. Combined immunodeficiency: the Middle East experience. The Journal of allergy and clinical immunology. 2013 Mar:131(3):658-60. doi: 10.1016/j.jaci.2012.11.033. Epub 2013 Jan 12
[PubMed PMID: 23321211]
[9]
Chinn IK, Shearer WT. Severe Combined Immunodeficiency Disorders. Immunology and allergy clinics of North America. 2015 Nov:35(4):671-94. doi: 10.1016/j.iac.2015.07.002. Epub
[PubMed PMID: 26454313]
[10]
Staines Boone AT, Chinn IK, Alaez-Versón C, Yamazaki-Nakashimada MA, Carrillo-Sánchez K, García-Cruz MLH, Poli MC, González Serrano ME, Medina Torres EA, Muzquiz Zermeño D, Forbes LR, Espinosa-Rosales FJ, Espinosa-Padilla SE, Orange JS, Lugo Reyes SO. Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency. Case Series and Review of the Literature. Frontiers in pediatrics. 2018:6():426. doi: 10.3389/fped.2018.00426. Epub 2019 Jan 21
[PubMed PMID: 30719430]
Level 2 (mid-level) evidence
[11]
Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AA, Agarwal-Hashmi R, Aznar CP, Butte MJ, Cowan MJ, Dorsey MJ, Dvorak CC, Kapoor N, Kohn DB, Markert ML, Moore TB, Naides SJ, Sciortino S, Feuchtbaum L, Koupaei RA, Puck JM. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017. Pediatrics. 2019 Feb:143(2):. doi: 10.1542/peds.2018-2300. Epub
[PubMed PMID: 30683812]
[12]
Murata C, Ramírez AB, Ramírez G, Cruz A, Morales JL, Lugo-Reyes SO. [Discriminant analysis to predict the clinical diagnosis of primary immunodeficiencies: a preliminary report]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993). 2015 Apr-Jun:62(2):125-33
[PubMed PMID: 25958376]
[13]
Routes J, Abinun M, Al-Herz W, Bustamante J, Condino-Neto A, De La Morena MT, Etzioni A, Gambineri E, Haddad E, Kobrynski L, Le Deist F, Nonoyama S, Oliveira JB, Perez E, Picard C, Rezaei N, Sleasman J, Sullivan KE, Torgerson T. ICON: the early diagnosis of congenital immunodeficiencies. Journal of clinical immunology. 2014 May:34(4):398-424. doi: 10.1007/s10875-014-0003-x. Epub 2014 Mar 12
[PubMed PMID: 24619621]
[14]
Kirschfink M, Mollnes TE. Modern complement analysis. Clinical and diagnostic laboratory immunology. 2003 Nov:10(6):982-9
[PubMed PMID: 14607856]
[15]
Dosanjh A. Autoimmunity and Immunodeficiency. Pediatrics in review. 2015 Nov:36(11):489-94; quiz 495. doi: 10.1542/pir.36-11-489. Epub
[PubMed PMID: 26527628]
[16]
De Rose DU,Giliani S,Notarangelo LD,Lougaris V,Lanfranchi A,Moratto D,Martire B,Specchia F,Tommasini A,Plebani A,Badolato R, Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): Not only infections, but high risk of autoimmune complications. Clinical immunology (Orlando, Fla.). 2018 Jun;
[PubMed PMID: 29548898]
[17]
Shamriz O, Chandrakasan S. Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders. Immunology and allergy clinics of North America. 2019 Feb:39(1):113-128. doi: 10.1016/j.iac.2018.08.003. Epub 2018 Nov 1
[PubMed PMID: 30466768]
Level 3 (low-level) evidence
[18]
Borzutzky A, Crompton B, Bergmann AK, Giliani S, Baxi S, Martin M, Neufeld EJ, Notarangelo LD. Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter. Clinical immunology (Orlando, Fla.). 2009 Dec:133(3):287-94. doi: 10.1016/j.clim.2009.08.006. Epub 2009 Sep 9
[PubMed PMID: 19740703]
[19]
Tanaka R, Tachibana K, Suda K, Kondo H, Noguchi M. A severe combined immunodeficiency disease mouse model of human adenocarcinoma with lepidic-predominant growth. Pathology, research and practice. 2018 Dec:214(12):2000-2003. doi: 10.1016/j.prp.2018.09.021. Epub 2018 Sep 28
[PubMed PMID: 30287185]